Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Payables (2017 - 2025)

Catheter Precision has reported Payables over the past 9 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Payables fell 1.75% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 1.75% year-over-year, with the annual reading at $1.8 million for FY2025, 1.75% down from the prior year.
  • Payables was $1.8 million for Q4 2025 at Catheter Precision, up from $1.4 million in the prior quarter.
  • Over five years, Payables peaked at $14.3 million in Q3 2023 and troughed at $92000.0 in Q4 2022.
  • The 5-year median for Payables is $988000.0 (2021), against an average of $2.4 million.
  • Year-over-year, Payables soared 3018.91% in 2023 and then tumbled 94.21% in 2024.
  • A 5-year view of Payables shows it stood at $988000.0 in 2021, then crashed by 90.69% to $92000.0 in 2022, then skyrocketed by 604.35% to $648000.0 in 2023, then skyrocketed by 182.41% to $1.8 million in 2024, then dropped by 1.75% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Payables are $1.8 million (Q4 2025), $1.4 million (Q3 2025), and $2.1 million (Q2 2025).